Approval · Notice of Compliance 21998 · 2019
METHOTREXATE: Notice of Compliance 21998
Issued March 21, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21998
- Date
- March 21, 2019
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Product name change. revisions to the product monograph and product labels
- Canadian reference product
- METHOTREXATE (Wyeth-Ayerst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE SODIUM 2.5 MG per TAB